Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Dermatol. 2008 Sep;144(9):1106-9. doi: 10.1001/archderm.144.9.1106.

Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.

Author information

1
Department of Dermatology, Hospital Clínic, University of Barcelona, Barcelona, Spain. 26305jmm@comb.es
PMID:
18794453
DOI:
10.1001/archderm.144.9.1106
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center